Eli Lilly has seen tremendous growth from its new GLP-1 drugs, which people have been using for weight loss. Sales growth should continue as the company increases production and looks to win ...

Paulo Nunes dos Santos / Bloomberg via Getty Images Eli Lilly will report third-quarter earnings Wednesday morning, with the focus remaining on the production and sales of its popular weight-loss ...

Yet, Eli Lilly's GLP-1 medications are helping it compete with the leader. Plus, Lilly also has several other promising catalysts to consider. These are two of healthcare's biggest darlings right ...

Coming off a brutal 41-10 loss to Texas A&M, Missouri head coach Eli Drinkwitz was eager to see the way his team would respond. Here's all he had to say after the team's win to round out its non ...

Eli Iserbyt's 2024-25 cyclocross got off to an inauspicious start last week after the Belgian was disqualified from his first race of the season, the Exact Cross in Beringen, for intentionally ...

Last week, the Food and Drug Administration declared an end to the shortage of Eli Lilly’s tirzepatide, sold under the brand name Mounjaro for diabetes and Zepbound for obesity. The move was a ...

A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among patients in a clinical trial, new data reported Tuesday show.

Race officials disqualified Eli Iserbyt (Pauwels Sauzen-Bingoal) from Exact Cross series Beringen on Saturday for intentionally stomping on Ryan Kamp's (Alpecin-Deceuninck) bike after the pair ...

Nico Chen has given his Buy rating due to a combination of factors including Eli Lilly’s strong revenue growth and the potential expansion of its diabetes medication Mounjaro. Chen recognizes ...

Speaking shortly after his firm announced it “anticipates making £279m investment over three years” in the UK life sciences sector, Eli Lilly chief executive David Ricks warned that due to ...

The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are ...

Also Read: Eli Lilly’s Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron’s Dupixent In the LUCENT-3 trial, mirikizumab helped patients ...